Patents Represented by Attorney James W. Williams, Jr.
  • Patent number: 4983510
    Abstract: Enzymes such as L-methionine gamma lyase, L-lysine decarboxylase, L-aspartase and L-tryptophanase are immobilized by contacting with a latex of polymer particles having a negative surface charge such that the electrophoretic mobility of the latex has a negative value of -2.0 10.sup.-8 m.sup.2 V.sup.-1 sec.sup.-1 or below when measured at pH 7 in 0.01M KNO.sub.3 and a polymer solids concentration of 30 mg/l. The polymer particles also have a hydrophobic surface such that the contact angle of a 1 microliter droplet of distilled water with a plane horizontal surface formed by drying and compacting the latex particles is 70.degree. or more. The resultant-enzyme/polymer particles can be used for assaying amino acids corresponding to the specific enzyme immobilized in aqueous solutions using an electrosensor comprising a pH-sensitive electrode located in a sensing zone or chamber containing the enzyme/polymer particles as an aqueous dispersion or in water-dispersible form.
    Type: Grant
    Filed: October 26, 1988
    Date of Patent: January 8, 1991
    Assignee: Monsanto Company
    Inventors: Pierre F. Lardinois, Paul G. Rouxhet, William E. E. Stone, Kenneth M. Baker, Alain E. Baudichau
  • Patent number: 4975529
    Abstract: A method of recovering biologically active somatotropins which are produced as insoluble refractile bodies in transformed microorganisms which comprises dissolving refractile bodies in a denaturant and 2-amino-2-methyl-1-propanol, homogenizing, and diluting to fold.
    Type: Grant
    Filed: August 18, 1989
    Date of Patent: December 4, 1990
    Assignee: Monsanto Company
    Inventors: Ronald B. Frazier, Yasuo Konishi
  • Patent number: 4973602
    Abstract: Novel N-aryl derivatives of 1,4-dideoxy-1,4-imino-L-arabinitol and their acylated derivatives are disclosed. These compounds have useful antiviral activity.
    Type: Grant
    Filed: September 26, 1989
    Date of Patent: November 27, 1990
    Assignee: G. D. Searle & Co.
    Inventors: Francis J. Koszyk, Richard A. Partis, Richard A. Mueller
  • Patent number: 4966852
    Abstract: A cDNA clone having a base sequence for human tissue factor inhibitor (TFI) has been developed and characterized and the amino acid sequence of the TFI has been determined.
    Type: Grant
    Filed: November 23, 1987
    Date of Patent: October 30, 1990
    Assignees: Monsanto Company, Washington University
    Inventors: Tze-Chein Wun, Kuniko K. Kretzmer, George J. Broze, Jr.
  • Patent number: 4963665
    Abstract: The invention provides DNA sequences encoding a human preproinsulin-like growth factor I protein and novel extension peptides. A novel preproinsulin-like growth factor I protein and novel extension peptides are also provided. The present invention further provides a human IGF-I gene which has been sequenced and which encodes at least two preproinsulin-like growth factor-I proteins. Various genes and DNA sequences useful in producing essentially pure mature IGF-I, preproinsulin-like growth factor I proteins and IGF-I gene related proteins are also provided.
    Type: Grant
    Filed: November 20, 1986
    Date of Patent: October 16, 1990
    Assignee: Washington University
    Inventors: Peter S. Rotwein, Gwen G. Krivi
  • Patent number: 4963357
    Abstract: A modified tissue plasminogen activator having an improved in vivo half-life characterized in that the normal protein moiety of 527 amino acids is mutated at the site Cys73.fwdarw.Arg.
    Type: Grant
    Filed: January 29, 1988
    Date of Patent: October 16, 1990
    Assignee: Monsanto Company
    Inventors: Leslie D. Bell, Ernest J. Mayer, Mark O. Palmier, H. Eser Tolunay, Thomas G. Warren, Tze-Chein Wun
  • Patent number: 4959494
    Abstract: A method for oxidizing organic compounds by contacting organic compounds with molecular oxygen in the presence of a noble metal pyrochlore having the formula:A.sub.2+x B.sub.2-x O.sub.7-ywherein A is a pyrochlore structure metal cation, and B is one or more of Ru, Rh, Ir, Os, and Pt; x and y are greater than or equal to 0 and less than or equal to 1.0, at a temperature up to about 200.degree. C.
    Type: Grant
    Filed: July 6, 1987
    Date of Patent: September 25, 1990
    Assignee: Monsanto Company
    Inventor: Timothy R. Felthouse
  • Patent number: 4957926
    Abstract: A method is disclosed for the treatment of herpesvirus infections comprising treating the infected host with an effective amount of an N-alkyl derivative of deoxynojirimycin in which the alkyl group contains from one to about six carbon atoms, and preferably is butyl.
    Type: Grant
    Filed: December 22, 1988
    Date of Patent: September 18, 1990
    Assignee: Monsanto Company
    Inventors: Gary S. Jacob, A. Stanley Tyms, Thomas W. Rademacher, Raymond A. Dwek
  • Patent number: 4957863
    Abstract: A method is disclosed for increasing the yield of t-PA in culture of mammalian cells comprising introducing antibodies to the t-PA of said cells into the cell culture nutrient medium, allowing the cells to grow, and then recovering t-PA from the t-PA-antibody complex thus found in the conditioned medium by exchanging antibody in the complex for t-PA antibody immobilized on an inert support.
    Type: Grant
    Filed: January 26, 1988
    Date of Patent: September 18, 1990
    Assignee: Monsanto Company
    Inventors: Michael A. Sanzo, Medora M. Hardy, Joseph Feder
  • Patent number: 4940835
    Abstract: This invention involves a cloning or expression vector comprising a gene which encodes 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) polypeptide which, when expressed in a plant cell contains a chloroplast transit peptide which allows the polypeptide, or an enzymatically active portion thereof, to be transported from the cytoplasm of the plant cell into a chloroplast in the plant cell, and confers a substantial degree of glyphosate resistance upon the plant cell and plants regenerated therefrom.The EPSPS coding sequence may be ligated to a strong promoter, such as the 35S promoter from cauliflower mosaic virus, to create a chimeric gene. Such genes can be inserted into plant transformation vectors, and subsequently introduced into plant cells. Plant cells transformed using such genes and plants regenerated therefrom have been shown to exhibit a substantial degree of glyphosate resistance.
    Type: Grant
    Filed: July 7, 1986
    Date of Patent: July 10, 1990
    Assignee: Monsanto Company
    Inventors: Dilip M. Shah, Stephen G. Rogers, Robert B. Horsch, Robert T. Fraley
  • Patent number: 4939288
    Abstract: Method for preparing a biologically active 2-substituted succinic acid derivative involving asymmetrically catalytically hydrogenating the corresponding 2(E)-alkylidene succinate derivative in the presence of a rhodium complexed (R,R)-bisphosphine compound.
    Type: Grant
    Filed: January 23, 1989
    Date of Patent: July 3, 1990
    Assignee: Monsanto Company
    Inventor: John J. Talley
  • Patent number: 4937357
    Abstract: N-alkyl, N-hydroxylalkyl and N-alkanoyl derivatives of 1,4-dideoxy-1,4-imino-L-arabinitol are disclosed in which the alkyl group has from 4 to about 9 carbon atoms, the hydroxyalkyl group has from 2 to about 5 carbon atoms and the alkanoyl group has from 3 to about 12 carbon atoms. These compounds are useful intermediates for the preparation of acylated derivatives thereof which have antiviral activity.
    Type: Grant
    Filed: September 26, 1989
    Date of Patent: June 26, 1990
    Assignee: G. D. Searle & Co.
    Inventors: Francis J. Koszyk, Richard A. Partis, Richard A. Mueller
  • Patent number: 4933278
    Abstract: A method is disclosed for determining the number of cells in cell culture which comprises lysing the cells and incubating the cell lysate with p-nitrophenyl phosphate for a predetermined period of time at acid pH and at 35.degree.-38.degree. C., and then measuring the color development at 400 to 420 nanometers and comparing with a control. The method is accurate, sensitive, and well-suited for automation, and thereby provides for the rapid sampling of large numbers of cell culture where the cells are grown under very sparse conditions.
    Type: Grant
    Filed: January 28, 1987
    Date of Patent: June 12, 1990
    Assignee: Monsanto Company
    Inventor: Daniel T. Connolly
  • Patent number: 4927630
    Abstract: Normal human colon fibroblast tissue plasminogen activator is separated by lysine-Sepharose affinity chromatography into Types I and II glycoforms and characterized with respect to the relative incidence of each type of oligosaccharide comprising the respective Types I and II glycoforms.
    Type: Grant
    Filed: March 11, 1988
    Date of Patent: May 22, 1990
    Assignee: Monsanto Company
    Inventors: Joseph Feder, Susan C. Howard, Arthur J. Wittwer, Thomas W. Rademacher, Raj B. Parekh, Raymond A. Dwek
  • Patent number: 4923818
    Abstract: The cDNA clone representing the full size human type IV collagenase (gelatinase) is disclosed.
    Type: Grant
    Filed: May 15, 1989
    Date of Patent: May 8, 1990
    Assignee: Washington University
    Inventors: Gregory I. Goldberg, Arthur Z. Eisen
  • Patent number: 4912207
    Abstract: A cDNA having a base sequence for human thrombomodulin has been cloned and characterized and the amino acid sequence of the human thrombomodulin has been determined.
    Type: Grant
    Filed: May 6, 1987
    Date of Patent: March 27, 1990
    Assignee: Washington University
    Inventors: Philip W. Majerus, J. Evan Sadler
  • Patent number: 4910310
    Abstract: Novel intermediates and method for the chemical synthesis of N-substituted 1,5-dideoxy-1,5-imino-L-fucitol derivatives are provided. A preferred intermediate is 1,5-dideoxy-1,5-imino-3, 4-O-isopropylidene-L-fucitol which is used to prepare the HIV inhibitor 1,5-dideoxy-1,5-imino-[N-.omega.-methyl caproate]-L-fucitol. These compounds are prepared in a short synthesis from the known compound 2,3-O-isopropylidene-D-lyxono-1,4-lactone or in a multi-step synthesis from D-galactose.
    Type: Grant
    Filed: October 3, 1988
    Date of Patent: March 20, 1990
    Assignee: G. D. Searle & Co.
    Inventors: Arthur L. Campbell, James R. Behling, Kevin A. Babiak, John S. Ng, Richard A. Mueller, George W. J. Fleet
  • Patent number: 4894388
    Abstract: The specificity of glycosidase inhibitory activity of the novel 1,4-dideoxy-1,4-imino-L-allitol is substantially changed by substituting the ring nitrogen with an alkyl or benzyl substituent.
    Type: Grant
    Filed: December 22, 1988
    Date of Patent: January 16, 1990
    Assignee: Monsanto Company
    Inventor: George W. J. Fleet
  • Patent number: 4891312
    Abstract: A monoclonal antibody is disclosed which is specific for human colon fibroblast-derived tissue plasminogen activator (t-PA), and which is useful for immunoaffinity chromatography purification of t-PA and determination of t-PA in a biological sample.
    Type: Grant
    Filed: January 6, 1989
    Date of Patent: January 2, 1990
    Assignee: Monsanto Company
    Inventors: Jon P. Schaumann, Jitka V. Olander, Nicholaos K. Harakas, Joseph Feder
  • Patent number: 4891190
    Abstract: An incrustation resistive crystallizer apparatus is disclosed. The crystallizer housing has conduit means for ingress of solution to be crystallized, separate conduit means for ingress and egress of cooling fluid, means for recovery of mother liquor and product crystals either together or separately. A plurality of essentially horizontal perforated plates substantially conforming to the interior shape of the housing are vertically spaced along the housing length. A support member capable of translational movement along the housing length holds the plates in the above-described position. A plurality of mobile bodies are disposed on the upper surface of the plates. A heat transfer conduit disposed substantially parallel to the coaxial support member penetrates through apertures in the horizontal plates. A compound excitation device adapted to produce two waveforms is attached to the support member. The first waveform causes translational plate movement for scraping the surface of the heat transfer conduit.
    Type: Grant
    Filed: May 29, 1985
    Date of Patent: January 2, 1990
    Assignee: Monsanto Company
    Inventors: Don E. Carter, Yung C. Hsu